Astonea Labs Ltd

Director re-appointment

• Ms. Pooja Singh was re-appointed as Director at the AGM on 21 August 2026.
• She was liable to retire by rotation and offered for re-appointment, which was approved.
• Term: re-appointment as Director liable to retirement by rotation under Companies Act 2013 and AoA.
• Brief profile: B.Pharm with over eight years in QA, regulatory affairs, and pharma operations.
• Current role: heads the Drug Regulatory Affairs Department since 2021.
• Expertise: Quality Assurance, Regulatory Compliance, DRA, and pharmaceutical operations.
• Relationship: not related to any Director, Manager or KMP.
• Directorships in listed entities: NIL; CSR Committee: Member of CSR Committee of Astonea Labs.
• No listed-entity resignations disclosed in last three years.
• Shareholding in the company: NIL.

AGM details

• Date and time: 21 August 2026 at 11:30 AM; mode: physical at Chandigarh hotel.
• Voting cut-off date: 14 August 2026 for voting rights.

Key resolutions

• Ordinary: Standalone financials adopted for year ended 31 March 2026; passed.
• Ordinary: Consolidated financials adopted; passed.
• Ordinary: Re-appointment of Ms. Pooja Singh by rotation; passed.
• Ordinary: Ratification of cost auditor remuneration for FY 2027; passed.
• Special: Alter MOA object clause; passed.
• Special: Incorporation and investment in Indian subsidiary companies; passed.

Voting results

• Item 1: Passed; 100% in favour.
• Item 2: Passed; 100% in favour.
• Item 3: Passed; 100% in favour.
• Item 4: Passed; 100% in favour.
• Item 5: Passed; 100% in favour.
• Item 6: Passed; 100% in favour.

Dividend

• No dividend proposed or declared.

Director changes

• Pooja Singh re-appointed as director; retires by rotation.

Auditor appointments

• Cost auditor remuneration for FY 2027 ratified; no other changes.

Related party transactions

• No material RPTs approved at the AGM.

AGM Details

• Date and time: 21 August 2026, 11:30 AM–12:30 PM IST, in-person.
• Venue: Mercure Hotel, Chandigarh.

Resolutions

• Ordinary: adopt Standalone Financial Statements for FY2025-26; Board and Auditors' reports.
• Ordinary: adopt Consolidated Financial Statements for FY2025-26 with auditors' report.
• Ordinary: re-appoint Ms. Pooja Singh by rotation.
• Ordinary: ratify remuneration of Balwinder & Associates as Cost Auditor for FY ending 31 March 2027.
• Special: alter Object Clause of Memorandum of Association.
• Special: approve incorporation and investment in subsidiary companies in India.

Voting status

• Voting results to be submitted to stock exchange within two working days and uploaded on the company's website.

Consolidated results and approvals

• Audited Consolidated Financial Results for half year and year ended 31 March 2026 approved.
• Audited Consolidated Financial Statements and unmodified auditors' report noted and submitted to the Stock Exchange.
• Mr. Pardeep Dalal authorized as signing authority for signing and certifying results.
• Trading window reopened 48 hours after declaration and approval.
• Consolidated FY26 approved after receipt of associate company's audit report.

Board reports and annual report

• Draft Board’s Report for FY2025-26 approved.
• Annual Report for FY2025-26 approved and to be signed by Directors.

Director retirement and re-appointment

• Retirement by rotation noted for Ms. Pooja Singh; re-appointment proposal to AGM.
• Ms. Pooja Singh consent and declarations received; subject to member approval.

MOA alteration

• Alteration of MOA Object Clause approved to enable pharma manufacturing and distribution.
• Special Resolution required at ensuing General Meeting.

Subsidiaries

• Approval to incorporate and invest in Indian subsidiary companies.
• Directors and officers authorized to take necessary steps.

AGM and e-voting

• Notice for 9th AGM scheduled for 21 Aug 2026 at Chandigarh approved.
• NSDL appointed as e-voting agency for AGM; remote e-voting facility planned.
• Sahil Malhotra appointed Scrutinizer for AGM.

Other actions and tax auditor

• Deferral of termination of agreements with Astonea One Pvt Ltd.
• Amendment to Item 15 of May 2026 resolution updating tax references.
• Re-appointment of M/s Avnish Sharma & Associates as Tax Auditor for 2026-27; remuneration approved.

Meeting Details

• Date: 24 July 2026; Time: not disclosed; Location: 63, Industrial Area, Phase-2, Industrial Estate Panchkula, Haryana.

Key Agenda Items

• Consolidated Audited Financial Results for year ended 31 March 2026.
• Notice of 9th AGM for financial year 2025-26.
• Annual Report for year ended 31 March 2026.
• Proposed alteration of the Memorandum of Association.
• Incorporation of, and investment in, a Subsidiary / Wholly Owned Subsidiary in India.
• Any other matter with permission of the Chairman.

Other Notes

• Trading window closed from 1 April 2026; stays closed 48 hours after results declaration.
• Standalone Audited Financial Results for year ended 31 March 2026 were approved and announced on 30 May 2026.
• Consolidated results scheduled to be announced on 24 July 2026.

Key details

• Sale deed completed for two commercial units FF-508/FF-509 at JMD Megapolis, Gurugram, on 17 July 2026.
• Sale consideration approx Rs 1,49,71,000 per unit (FF-508 and FF-509).
• Total consideration approximately Rs 2,99,42,000 for both units.
• Purchasers are jointly Mr. Suresh Kumar Satija and Mrs. Santosh Satija.
• Not a related party transaction; no promoter group interest.
• Rationale: monetization of immovable assets and asset-portfolio optimization; no material adverse impact.
• Consideration received in accordance with sale deed terms; completion upon registration.
• Not expected to materially impact operations or business position.
• Completion disclosed under SEBI LODR Regulation 30 as required.

Regulatory inspection completed

• Completed inspection of manufacturing facility at Village Haripur, Tehsil Raipur Rani, Panchkula, Haryana; certificate received from SBDMA, Yemen.

Dematerialisation/rematerialisation status

• No dematerialisation/rematerialisation requests were received during the reporting period.
• Details of dematerialised/rematerialised securities were furnished to all stock exchanges where shares are listed.